Cai Jiacheng, Chen Dahua, Luo Wenjing, Xu Feng, Feng Xiaofeng, Zhang Liangshun, Liu Huiwei, Shen Jianwei, Ye Hua
The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China.
Front Nutr. 2024 Mar 19;11:1366843. doi: 10.3389/fnut.2024.1366843. eCollection 2024.
Metabolically Associated Fatty Liver Disease (MAFLD) marks a progression from the previous paradigm of Non-Alcoholic Fatty Liver Disease (NAFLD), presenting a redefined diagnostic framework that accentuates metabolic factors while recognizing non-alcoholic contributors. In our investigation, our principal aim was to scrutinize the conceivable correlation between diverse serum folate levels and the prevalence of MAFLD and liver fibrosis.
In our investigation, we conducted an extensive analysis utilizing data derived from the National Health and Nutrition Examination Survey (NHANES) across the years 2017-2020. We aimed to investigate the association between different serum folate concentrations and the prevalence of MAFLD and liver fibrosis by comprehensive multivariate analysis. This analytical approach considered various variables, encompassing sociodemographic characteristics, lifestyle factors, hypertension, and diabetes. By including these potential confounders in our analysis, we aimed to ensure the stability of the findings regarding the association between different serum folate concentrations and the development of MAFLD and liver fibrosis.
In our investigation, we utilized multiple linear regression models to thoroughly analyze the data, revealing noteworthy insights. Evidently, elevated levels of both total folate and 5-MTHF exhibited a distinct negative correlation with CAP, while 5-MTHF demonstrated a notable negative correlation with LSM. Furthermore, multiple logistic regression models were employed for an in-depth examination of the data. As the concentrations of total folate and 5-MTHF in the serum increased, a substantial decrease in the likelihood of MAFLD and liver fibrosis occurrence was observed.
The findings of this investigation robustly suggest the prevalence of MAFLD and liver fibrosis decreased significantly with the increase of serum concentrations of total folate and 5-MTHF.
代谢相关脂肪性肝病(MAFLD)标志着从先前的非酒精性脂肪性肝病(NAFLD)模式的进展,提出了一个重新定义的诊断框架,该框架在认识到非酒精性因素的同时强调代谢因素。在我们的调查中,我们的主要目的是仔细研究不同血清叶酸水平与MAFLD患病率和肝纤维化之间可能存在的相关性。
在我们的调查中,我们利用了2017 - 2020年期间美国国家健康与营养检查调查(NHANES)的数据进行了广泛分析。我们旨在通过全面的多变量分析来研究不同血清叶酸浓度与MAFLD患病率和肝纤维化之间的关联。这种分析方法考虑了各种变量,包括社会人口统计学特征、生活方式因素、高血压和糖尿病。通过在我们的分析中纳入这些潜在的混杂因素,我们旨在确保关于不同血清叶酸浓度与MAFLD和肝纤维化发展之间关联的研究结果的稳定性。
在我们的调查中,我们使用多元线性回归模型对数据进行了全面分析,揭示了值得注意的见解。显然,总叶酸和5 - 甲基四氢叶酸水平升高均与受控衰减参数(CAP)呈现出明显的负相关,而5 - 甲基四氢叶酸与肝脏硬度值(LSM)呈现出显著的负相关。此外,我们采用多元逻辑回归模型对数据进行深入检查。随着血清中总叶酸和5 - 甲基四氢叶酸浓度的增加,观察到MAFLD和肝纤维化发生的可能性大幅降低。
本调查结果有力地表明,随着血清总叶酸和5 - 甲基四氢叶酸浓度的增加,MAFLD和肝纤维化的患病率显著降低。